• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
AIDS - Related Cancer - Pipeline Review, H1 2012 Product Image

AIDS - Related Cancer - Pipeline Review, H1 2012

  • Published: April 2012
  • 124 pages
  • Global Markets Direct

AIDS - Related Cancer – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'AIDS - Related Cancer - Pipeline Review, H1 2012', provides an overview of the AIDS - Related Cancer therapeutic pipeline. This report provides information on the therapeutic development for AIDS - Related Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS - Related Cancer. 'AIDS - Related Cancer - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for AIDS - Related Cancer.
- A review of the AIDS - Related Cancer products under development by companies READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
AIDS - Related Cancer Overview
Therapeutics Development
An Overview of Pipeline Products for AIDS - Related Cancer
AIDS - Related Cancer Therapeutics under Development by Companies
AIDS - Related Cancer Therapeutics under Investigation by Universities/Institutes
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
AIDS - Related Cancer Therapeutics – Products under Development by Companies
AIDS - Related Cancer Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in AIDS - Related Cancer Therapeutics Development
Aphios Corporation
PTC Therapeutics, Inc.
AIDS - Related Cancer – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Dermos - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PTC299 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Doxil + Methotrexate + Prednisone + Vincristine Sulfate + Sargramostim - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rapamycin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bevacizumab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cetuximab + Fluoroucacil + Cisplatin + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gleevec - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SU5416 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
cART + R-EPOCH - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Interferon Alfa-2b + Didanosine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
G-CSF + Cyclophosphamide + Etoposide + Lomustine + Procarbazine + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bortezomib - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lenalidomide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lenalidomide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Liposomal Doxorubicin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Liposomal Doxorubicin + Bleomycin + Vincristine + Filgrastim - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Methotrexate + Zidovudine + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Halofuginone Hydrobromide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Filgrastim + Cyclophosphamide + Cytarabine + Methotrexate + Pegylated Liposomal Doxorubicin Hydrochloride + Prednisone + Vincristine Sulfate + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MEAM + HAART + Stem Cell Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BCNU + Etoposide + Cytarabine + Melphalan + Autologous Hematopoietic Cell Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Interferon alfa-2b + Zidovudine + Sargramostim - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Interferon alfa-n1 + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Interferon beta-1b + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EPOCH Regimen + Methotrexate + Prednisone + Cytarabine + Filgrastim - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EPOCH Regimen + Methotrexate + Prednisone + Cytarabine + Filgrastim - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Filgrastim + Pegfilgrastim + Rituximab + Cyclophosphamide + Cytarabine + Doxorubicin Hydrochloride + Etoposide + Ifosfamide + Leucovorin Calcium + Liposomal Cytarabine + Methotrexate + Therapeutic Hydrocortisone + Vincristine Sulfate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bleomycin Sulfate + Vincristine Sulfate + Doxorubicin Hydrochloride + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Methotrexate + rituximab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lenalidomide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
R-EPOCH + cART - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sunitinib - Drug Profile
Product Description
Mechanism of Action
R&D Progress
G-CSF + Cyclophosphamide + Etoposide + Lomustine + Procarbazine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
G-CSF + Cyclophosphamide + Etoposide + Lomustine + Procarbazine Hydrochloride + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ProMACE-CytaBOM + TMP-SMX + G-CSF + Radiation therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bleomycin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Filgrastim + Rituximab + Sargramostim + Cyclophosphamide + Doxil + Prednisone + Vincristine Sulfate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rituximab + EPOCH - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rituximab + EPOCH + Vorinostat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
R-CHOP - Drug Profile
Product Description
Mechanism of Action
R&D Progress
R-CHOP + Vorinostat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etoposide + Methylprednisolone Sodium Succinate + Carboplatin + AraC + Rituximab + MCNU + L-PAM + Autologous Peripheral Blood Stem Cell Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HAART + Bevacizumab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CHOP + Rituximab + Peripheral Blood Stem Cell Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HAART + Methotrexate + Rituximab + Leucovorin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Velcade + Carboplatin + Dexamethasone + Etoposide + Ifosfamide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fludarabine + Busulfan + Melphalan + Cyclophosphamide + Total Body Irradiation + Allogeneic Hematopoietic Cell Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AIDS - Related Cancer Therapeutics – Drug Profile Updates
AIDS - Related Cancer Therapeutics – Discontinued Products
AIDS - Related Cancer Therapeutics - Dormant Products
AIDS - Related Cancer – Product Development Milestones
Featured News & Press Releases
Aug 05, 1997: Taxol Approved for Kaposi's Sarcoma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for AIDS - Related Cancer, H1 2012
Products under Development for AIDS - Related Cancer – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Comparative Analysis by Early Clinical Stage Development, H1 2012
Comparative Analysis by Pre-Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Aphios Corporation, H1 2012
PTC Therapeutics, Inc., H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Stage and Molecule Type, H1 2012
AIDS - Related Cancer Therapeutics – Drug Profile Updates
AIDS - Related Cancer Therapeutics – Discontinued Products
AIDS - Related Cancer Therapeutics – Dormant Products

List of Figures
Number of Products under Development for AIDS - Related Cancer, H1 2012
Products under Development for AIDS - Related Cancer – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Mid Clinical Stage Products, H1 2012
Early Clinical Stage Products, H1 2012
Pre-Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos